Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$5.27 - $6.64 $143,344 - $180,608
-27,200 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$5.06 - $6.36 $7,842 - $9,858
-1,550 Reduced 5.39%
27,200 $153,000
Q1 2018

Apr 16, 2018

BUY
$4.85 - $5.99 $10,912 - $13,477
2,250 Added 8.49%
28,750 $149,000
Q4 2017

Feb 09, 2018

SELL
$4.53 - $7.09 $56,172 - $87,916
-12,400 Reduced 31.88%
26,500 $120,000
Q3 2017

Oct 26, 2017

BUY
$5.71 - $6.9 $8,565 - $10,350
1,500 Added 4.01%
38,900 $244,000
Q2 2017

Aug 15, 2017

BUY
N/A
37,400
37,400 $229,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.43B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.